Here's Where This Fund Manager Says You Should Look for Stock-Market Bargains

Grounded in its mean-reversion philosophy, GMO advises avoiding the most expensive market segments, such as highly valued U.S. growth and AI stocks, while identifying opportunities elsewhere. Its Dynamic Allocation ETF (GMOD) underweights U.S. stocks and overweights Japan, emerging markets (ex-China), and intermediate-term bonds, citing higher expected returns and attractive valuations in these areas. GMO notes current fixed income yields are acceptable but highlights value and quality stocks outside the U.S. as primary opportunities, driven by relative cheapness and the strong dollar's valuation.

Analysis

GMO, operating under its mean-reversion philosophy, advises investors to exercise restraint by avoiding the most expensive segments of the global market, citing high valuations as a precursor to lower expected returns and elevated risk. John Thorndike, co-head of asset allocation, specifically highlights U.S. growth and AI-related stocks as areas with high valuations and expectations that warrant avoidance or underweighting. This cautious outlook aligns with the article's overall "mixed" sentiment and "cautious" tone.

The firm's actively managed GMO Dynamic Allocation ETF (GMOD) reflects this strategy by significantly underweighting U.S. stocks, given projected negative seven-year returns for U.S. large and small-cap equities as of September. Conversely, GMOD overweights Japan, emerging markets excluding China, and intermediate-term bonds, identifying these as regions and asset classes offering more attractive valuations and higher expected returns. The fund maintains a 60% stock, 40% bond allocation, but its equity book is fundamentally different from cap-weighted indices, focusing on quality and value.

GMO also points to a shifting investment thesis for the "Magnificent Six" companies, noting their increased capital expenditures for real-world investments, which now necessitate substantial returns to justify current valuations. Japan is identified as particularly attractive due to cheap valuations, improving corporate governance, and a favorable exchange rate for U.S. investors. Furthermore, the expensive U.S. dollar's valuation is considered a tailwind for non-U.S. equities, enhancing their appeal for U.S. investors.

Key Decisions for Investors

• Investors should critically assess their exposure to highly valued U.S. growth and AI-related stocks, given GMO's concerns about lower expected returns and increased risk.
• Diversification into non-U.S. equities, specifically Japan and emerging markets (excluding China), warrants consideration due to identified attractive valuations and higher expected returns.
• Evaluate the long-term investment thesis for large-cap growth companies, acknowledging their increased capital expenditure requirements and the need for substantial returns to justify current valuations.
• Maintain a strategic allocation to intermediate-term bonds for income and portfolio protection, while monitoring Federal Reserve policy for potential rate cuts that could impact fixed income attractiveness.